factor

(redirected from migration inhibitory factor)
Also found in: Dictionary, Thesaurus, Medical, Financial, Encyclopedia.

Factor

An event, circumstance, influence, or element that plays a part in bringing about a result.

A factor in a case contributes to its causation or outcome. In the area of Negligence law, the factors, or chain of causation, are important in determining whether liability ensues from a particular action done by the defendant.

factor

n. 1) a salesman who sells in his/her own name on behalf of others, taking a commission for services. 2) something that contributes to the result.

factor

(Commission merchant), noun agent, broker, commercial agent, delegate, deputy, envoy, interagent, manager, medium, middleman, one who sells for factorage, proctor, procurator, representative
Associated concepts: consignee, factors' lien

factor

(Ingredient), noun additive, agent, aid, aspect, cause, component, constituent, constitutive element, content, contributing force, determinant, element, elementary unit, feature, integral part, part, portion, segment, unit
See also: aspect, broker, cause, characteristic, component, constituent, dealer, deputy, determinant, element, feature, ingredient, member, part, plenipotentiary, portion, procurator, reason, represent, substitute

factor

1 a mercantile agent. An agent who is in the ordinary course of business entrusted with goods or documents of title representing goods with a view to their sale. A factor has a lien over goods entrusted to him; this lien covers any claims he may have against his principal arising out of the agency. Most factors will be mercantile agents (and have the powers of such) for the purposes of the Factors Act 1889. Under this Act, in certain circumstances a factor may pass a good title to goods entrusted to him.
2 an institution to whom a company assigns its book debts (see FACTORING).
3 in Scotland a landlord or superior's agent.
References in periodicals archive ?
The report reviews Macrophage Migration Inhibitory Factor (Glycosylation-Inhibiting Factor or L-Dopachrome Isomerase or MIF or EC 5.
Macrophage migration inhibitory factor is a therapeutic target in treatment of non-insulin-dependent diabetes mellitus.
Plasma concentrations of macrophage migration inhibitory factor are elevated in Pima Indians compared to Caucasians and are associated with insulin resistance.
2]), Extracellular signal-regulated protein kinase (Erk), Inducible nitric oxide synthase (iNOS), Inhibitory factor kinase1/2/3 (IKK1/2/3), Lipopolysaccharide (LPS), Macrophage migration inhibitory factor (MIF), Mitogen activated protein kinase (MAPK), Nuclear factor-kappa B (NF-[kappa]B), Nitric oxide (NO), Phosphatidylinositol 3-kinase (PI3K), Protein kinase Akt (Akt), T-helper 1 lymphocytes (Th1), Toll-like receptor 4(TLR4), Transcription factor E2F (E2F), Transcription factor Sp1 (SP1)
Is macrophage migration inhibitory factor (MIF) the control point of vascular hypo-responsiveness in septic shock?
Macrophage migration inhibitory factor levels correlate with fatal outcome in sepsis.
AVANIR's small molecule research targets macrophage migration inhibitory factor (MIF), a pro-inflammatory cytokine that is thought to play a critical role in the pathology of disorders such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease.
Two posters, Inhibition of Macrophage Migration Inhibitory Factor (MIF) Activities by AVP-13546, A Small Molecule Inhibitor, and Reduction of Multiple Pro-Inflammatory Mediators by an Orally Active Small Molecule Antagonist of Macrophage Migration Inhibitor Factor, AVP-13748, were presented today.
NASDAQ: DYAX) announced today a research collaboration with Baxter Healthcare Corporation (NYSE: BAX) to utilize Dyax's proprietary phage display technology to discover antibodies that block macrophage migration inhibitory factor (MIF), a clinical target to which Baxter has an exclusive license from Cytokine PharmaSciences, Inc.
It will allow the discovery and development of potential oral first-in-class compounds that inhibit Macrophage Migration Inhibitory Factor, a major regulatory cytokine that has been linked genetically to the pathogenesis of several autoimmune and inflammatory diseases.
AVANIR's pre-clinical drug candidate targeting microphage migration inhibitory factor (MIF).
to develop and commercialize antibody therapeutics against macrophage migration inhibitory factor (MIF) for the treatment of inflammatory and autoimmune diseases.

Full browser ?